8XFL

The Crystal Structure of MARK4 from Biortus.

PDB DOI: https://doi.org/10.2210/pdb8XFL/pdb

Classification: TRANSFERASE
Organism(s): Homo sapiens
Expression System: Escherichia coli
Mutation(s): No

Deposited: 2023-12-14 Released: 2023-12-27
Deposition Author(s): Wang, F., Cheng, W., Yuan, Z., Qi, J., Li, J.
Funding Organization(s): Not funded

Experimental Data Snapshot

Method: X-RAY DIFFRACTION
Resolution: 3.00 Å
R-Value Free: 0.270
R-Value Work: 0.207

wwPDB Validation 3D Report Full Report

This is version 1.0 of the entry. See complete history.

Literature

The Crystal Structure of MARK4 from Biortus.

Wang, F., Cheng, W., Yuan, Z., Qi, J., Li, J.

To be published.

Macromolecule Content

Total Structure Weight: 75.12 kDa
Atom Count: 4,713
Modelled Residue Count: 577
Deposited Residue Count: 654
Unique protein chains: 1

Macromolecules

Find similar proteins by:

(by identity cutoff) | 3D Structure

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
MAP/microtubule affinity-regulating kinase 4	A, B	327	Homo sapiens	Mutation(s): 0 Gene Names: MARK4
UniProt & NIH Common Fund Data Resources
Find proteins for Q96L34 (Homo sapiens) Explore Q96L34 Go to UniProtKB: Q96L34
PHAROS: Q96L34 GTEx: ENSG00000007047
Entity Groups
Sequence Clusters	30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt Group	Q96L34
Sequence Annotations Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

Method: X-RAY DIFFRACTION
Resolution: 3.00 Å
R-Value Free: 0.270
R-Value Work: 0.207
Space Group: C 1 2 1

Unit Cell:

Length ( Å )	Angle ( ˚ )
a = 114.447	α = 90
b = 78.103	β = 122
c = 86.155	γ = 90

Software Package:

Software Name	Purpose
REFMAC	refinement
XDS	data reduction
Aimless	data scaling
PHASER	phasing

Structure Validation

View Full Validation Report

Entry History & Funding Information

Deposition Data

Released Date: 2023-12-27

Deposition Author(s):

Funding Organization	Location	Grant Number
Not funded		--

Revision History (Full details and data files)

Version 1.0: 2023-12-27
Type: Initial release

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.